Diabetes Mellitus screening and associated factors in Peru: A cross-sectional analysis of a national health survey.

ABSTRACT: Screening rates for Type 2 diabetes mellitus (T2DM) in Peru remain low despite an increasing prevalence of the disease. In 2022, the American Diabetes Association (ADA) recommended screening adults aged 18-34 with overweight or obesity and at least one risk factor, including Latino ethnicity and lowered the universal screening age to 35 years. This study aimed to determine the T2DM screening prevalence in Peru and the factors associated with lack of screening in the population that meets ADA screening criteria. A cross-sectional, secondary data analysis was conducted based on the 2022 Peruvian Demographic and Health Survey database. Screening was defined as apparently healthy individuals having their blood glucose measured in the last year. Participants aged 18-34 years with overweight or

SUBMITTER: Arevalo-Rios ECE 

PROVIDER: S-EPMC12407462 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature